These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28264040)

  • 1. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.
    Gill J; Connolly P; Roth M; Chung SH; Zhang W; Piperdi S; Hoang B; Yang R; Guzik H; Morris J; Gorlick R; Geller DS
    PLoS One; 2017; 12(3):e0173322. PubMed ID: 28264040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
    Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
    Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.
    Geller DS; Singh MY; Zhang W; Gill J; Roth ME; Kim MY; Xie X; Singh CK; Dorfman HD; Villanueva-Siles E; Park A; Piperdi S; Gorlick R
    Clin Cancer Res; 2015 Jul; 21(13):3003-12. PubMed ID: 25472999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway.
    Liao D; Zhong L; Duan T; Zhang RH; Wang X; Wang G; Hu K; Lv X; Kang T
    Clin Cancer Res; 2015 Dec; 21(23):5349-59. PubMed ID: 26202947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway.
    Xie T; Ren HY; Lin HQ; Mao JP; Zhu T; Wang SD; Ye ZM
    Int J Oncol; 2016 May; 48(5):2098-112. PubMed ID: 26983669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9.
    Park H; Drevelle O; Daviau A; Senta H; Bergeron E; Faucheux N
    Anticancer Drugs; 2013 Mar; 24(3):278-90. PubMed ID: 23262982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elemene inhibits osteosarcoma growth by suppressing the renin‑angiotensin system signaling pathway.
    Ding L; Zhang G; Hou Y; Chen J; Yin Y
    Mol Med Rep; 2018 Jan; 17(1):1022-1030. PubMed ID: 29115494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.
    Yang X; Wang YP; Liu FX; Zeng K; Qian MQ; Chen G; Shi L; Zhu GX
    In Vitro Cell Dev Biol Anim; 2013 Apr; 49(4):270-8. PubMed ID: 23519562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
    Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
    Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
    Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
    BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models.
    Jian C; Tu MJ; Ho PY; Duan Z; Zhang Q; Qiu JX; DeVere White RW; Wun T; Lara PN; Lam KS; Yu AX; Yu AM
    Oncotarget; 2017 May; 8(19):30742-30755. PubMed ID: 28415566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KMT2C modulates migration and invasion processes in osteosarcoma cell lines.
    Chiappetta C; Carletti R; Della Rocca C; Di Cristofano C
    Pathol Res Pract; 2019 Oct; 215(10):152534. PubMed ID: 31337554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of bone morphogenetic activity in osteosarcoma tissue.
    Yoshikawa H; Takaoka K; Masuhara K; Ono K; Sakamoto Y
    Cancer; 1988 Feb; 61(3):569-73. PubMed ID: 3422172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
    Haydon RC; Luu HH; He TC
    Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.